Profil
Andreas Harstrick is currently the Chief Medical Officer at Affimed NV.
He previously worked as the Director at Lilly Oncology.
From 2008 to 2014, he served as the Senior Vice President-Medical Sciences at ImClone LLC.
He was also the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd. from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.
Aktiva positioner av Andreas Harstrick
| Företag | Position | Start |
|---|---|---|
| AFFIMED N.V. | Teknisk/Vetenskaplig/F&U Direktör | 2020-03-01 |
Tidigare kända positioner av Andreas Harstrick
| Företag | Position | Slut |
|---|---|---|
| MOLECULAR PARTNERS AG | Teknisk/Vetenskaplig/F&U Direktör | 2019-09-01 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Företagsledare/Principal | 2014-01-01 |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Företagsledare/Principal | 2008-01-01 |
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Direktör/Styrelseledamot | - |
Andreas Harstricks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
















